<?xml version='1.0' encoding='utf-8'?>
<document id="31952912"><sentence text="Identification and quantitation of enzyme and transporter contributions to hepatic clearance for the assessment of potential drug-drug interactions." /><sentence text="Drug-drug interactions (DDIs) involving drug-metabolizing enzymes and membrane transporters can lead to alteration in substrate drug (victim) exposure, and can influence the pharmacological and toxicological effects" /><sentence text=" In order to predict DDI potential, it is important to quantitatively characterize the major enzyme(s) and/or transporter(s) involved in the clearance of drugs, in terms of fraction metabolized (fm) and fraction transported (ft)" /><sentence text=" In this review, we discuss a strategy using Extended Clearance Classification System (ECCS) to identify the clearance mechanism(s) early in drug discovery, and subsequently rational staging of inÂ vitro characterization to determine fm and ft" /><sentence text=" In addition, the examples of complex DDIs due to involvement of transporter-enzyme interplay in the hepatic clearance are discussed" /><sentence text="" /></document>